Semin intervent Radiol 2013; 30(02): 133-140
DOI: 10.1055/s-0033-1342954
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surgical Management of Lung Cancer

Adam Lackey
1   Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York
,
Jessica S. Donington
1   Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
28 May 2013 (online)

Abstract

Surgery serves an important role in the diagnosis, staging, and definitive management of non–small cell lung cancer (NSCLC). Resection is the primary mode of treatment for stage I and II NSCLC and an important component of the multimodality approach to stage IIIA disease. Standard resections include removal of the lobe involved with tumor and systematic evaluation of ipsilateral hilar and mediastinal lymph nodes. For early stage disease the evolving surgical treatment goals are aimed at decreasing morbidity and mortality through less invasive approaches including video-assisted thoracoscopic surgery and robotic approaches, and potentially decreasing the volume of lung removed for select patients with well-staged small peripheral tumors. For patients with locally advanced disease, ongoing research is focused on appropriately identifying patients who will most benefit from the addition of surgery to a multimodality regime and safely integrating resection with chemotherapy and radiotherapy.

 
  • References

  • 1 Rami-Porta R, Crowley JJ, Goldstraw P. The revised TMN staging system for lung cancer. Ann Thor and Cardiovasc Surgery 2009; 15: 4-9
  • 2 Winton T, Livingston R, Johnson D , et al; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352 (25) 2589-2597
  • 3 Douillard JY, Rosell R, De Lena M , et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006; 7 (9) 719-727
  • 4 Pignon JP, Tribodet H, Scagliotti GV , et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. American Society of Clinical Oncology 2008; 26 (21) 3552-3559
  • 5 Wang KP, Brower R, Haponik EF, Siegelman S. Flexible transbronchial needle aspiration for staging of bronchogenic carcinoma. Chest 1983; 84 (5) 571-576
  • 6 Herth F, Becker HD, Ernst A. Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest 2004; 125 (1) 322-325
  • 7 Kokkonouzis I, Strimpakos AS, Lampaditis I, Tsimpoukis S, Syrigos KN. The role of endobronchial ultrasound in lung cancer diagnosis and staging: a comprehensive review. Clin Lung Cancer 2012; 13 (6) 408-415
  • 8 Tremblay A, Stather DR, Maceachern P, Khalil M, Field SK. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 2009; 136 (2) 340-346
  • 9 Darling GE, Allen MS, Decker PA , et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 trial. J Thorac Cardiovasc Surg 2011; 141 (3) 662-670
  • 10 Allen MS, Darling GE, Pechet TT , et al; ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006; 81 (3) 1013-1019 ; discussion 1019–1020
  • 11 Ginsberg RJ, Hill LD, Eagan RT , et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86 (5) 654-658
  • 12 Rocco G, Internullo E, Cassivi SD, Van Raemdonck D, Ferguson MK. The variability of practice in minimally invasive thoracic surgery for pulmonary resections. Thorac Surg Clin 2008; 18 (3) 235-247
  • 13 Jacobaeus H. Ueber die Zystotskopie bei Untersuchung seroser hohlungen Anzuqwnden. Munch Med Wochenschr 1910; 57: 2090-22092
  • 14 Kirby TJ, Mack MJ, Landreneau RJ, Rice TW. Initial experience with video-assisted thoracoscopic lobectomy. Ann Thorac Surg 1993; 56 (6) 1248-1252 ; discussion 1252–1253
  • 15 Kohno T, Murakami T, Wakabayashi A. Anatomic lobectomy of the lung by means of thoracoscopy. An experimental study. J Thorac Cardiovasc Surg 1993; 105 (4) 729-731
  • 16 Landreneau RJ, Hazelrigg SR, Mack MJ , et al. Postoperative pain-related morbidity: video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 1993; 56 (6) 1285-1289
  • 17 Walker WS, Carnochan FM, Pugh GC. Thoracoscopic pulmonary lobectomy. Early operative experience and preliminary clinical results. J Thorac Cardiovasc Surg 1993; 106 (6) 1111-1117
  • 18 McKenna Jr RJ, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006; 81 (2) 421-425 ; discussion 425–426
  • 19 Onaitis MW, Petersen RP, Balderson SS , et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006; 244 (3) 420-425
  • 20 Shaw JP, Dembitzer FR, Wisnivesky JP , et al. Video-assisted thoracoscopic lobectomy: state of the art and future directions. Ann Thorac Surg 2008; 85 (2) S705-S709
  • 21 Swanson SJ, Herndon II JE, D'Amico TA , et al. Video-assisted thoracic surgery lobectomy: report of CALGB 39802—a prospective, multi-institution feasibility study. J Clin Oncol 2007; 25 (31) 4993-4997
  • 22 Ali MK, Mountain CF, Ewer MS, Johnston D, Haynie TP. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. Chest 1980; 77 (3) 337-342
  • 23 Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail and high-risk patients: a case-control study. Ann Thorac Surg 1999; 68 (1) 194-200
  • 24 Sugiura H, Morikawa T, Kaji M, Sasamura Y, Kondo S, Katoh H. Long-term benefits for the quality of life after video-assisted thoracoscopic lobectomy in patients with lung cancer. Surg Laparosc Endosc Percutan Tech 1999; 9 (6) 403-408
  • 25 Petersen RP, Pham D, Burfeind WR , et al. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007; 83 (4) 1245-1249 ; discussion 1250
  • 26 Nakata M, Saeki H, Yokoyama N, Kurita A, Takiyama W, Takashima S. Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 2000; 70 (3) 938-941
  • 27 Dylewski MR, Ohaeto AC, Pereira JF. Pulmonary resection using a total endoscopic robotic video-assisted approach. Semin Thorac Cardiovasc Surg 2011; 23 (1) 36-42
  • 28 Gharagozloo F, Margolis M, Tempesta B. Robot-assisted thoracoscopic lobectomy for early-stage lung cancer. Ann Thorac Surg 2008; 85 (6) 1880-1885 ; discussion 1885–1886
  • 29 Cerfolio RJ, Bryant AS, Skylizard L, Minnich DJ. Initial consecutive experience of completely portal robotic pulmonary resection with 4 arms. J Thorac Cardiovasc Surg 2011; 142 (4) 740-746
  • 30 Giulianotti PC, Buchs NC, Caravaglios G, Bianco FM. Robot-assisted lung resection: outcomes and technical details. Interact Cardiovasc Thorac Surg 2010; 11 (4) 388-392
  • 31 Park BJ, Melfi F, Mussi A , et al. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg 2012; 143 (2) 383-389
  • 32 Park BJ, Flores RM. Cost comparison of robotic, video-assisted thoracic surgery and thoracotomy approaches to pulmonary lobectomy. Thorac Surg Clin 2008; 18 (3) 297-300 , vii
  • 33 Ginsberg RJ, Rubinstein LV. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60 (3) 615-622 ; discussion 622–623
  • 34 Jensik RJ, Faber LP, Milloy FJ, Monson DO. Segmental resection for lung cancer. A fifteen-year experience. J Thorac Cardiovasc Surg 1973; 66 (4) 563-572
  • 35 Ginsberg RJ, Hill LD, Eagan RT , et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86 (5) 654-658
  • 36 Keenan RJ, Landreneau RJ, Maley Jr RH , et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004; 78 (1) 228-233 ; discussion 228–233
  • 37 Harada H, Okada M, Sakamoto T, Matsuoka H, Tsubota N. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg 2005; 80 (6) 2041-2045
  • 38 Giraud P, Antoine M, Larrouy A , et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000; 48 (4) 1015-1024
  • 39 El-Sherif A, Fernando HC, Santos R , et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007; 14 (8) 2400-2405
  • 40 Sawabata N, Ohta M, Matsumura A , et al; Thoracic Surgery Study Group of Osaka University. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004; 77 (2) 415-420
  • 41 Kilic A, Schuchert MJ, Pettiford BL , et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg 2009; 87 (6) 1662-1666 ; discussion 1667–1668
  • 42 Schuchert MJ, Pettiford BL, Keeley S , et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007; 84 (3) 926-932 ; discussion 932–933
  • 43 Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003; 125 (4) 924-928
  • 44 Campione A, Ligabue T, Luzzi L , et al. Comparison between segmentectomy and larger resection of stage IA non-small cell lung carcinoma. J Cardiovasc Surg (Torino) 2004; 45 (1) 67-70
  • 45 Martin-Ucar AE, Nakas A, Pilling JE, West KJ, Waller DA. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005; 27 (4) 675-679
  • 46 Iwasaki A, Hamanaka W, Hamada T , et al. Comparison between a case-matched analysis of left upper lobe trisegmentectomy and left upper lobectomy for small size lung cancer located in the upper division. Thorac Cardiovasc Surg 2007; 55 (7) 454-457
  • 47 Shapiro M, Weiser TS, Wisnivesky JP, Chin C, Arustamyan M, Swanson SJ. Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer. J Thorac Cardiovasc Surg 2009; 137 (6) 1388-1393
  • 48 El-Sherif A, Gooding WE, Santos R , et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006; 82 (2) 408-415 ; discussion 415–416
  • 49 Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, Iwa T. Results of surgical treatment in patients with stage IIIA non-small-cell lung cancer. J Thorac Cardiovasc Surg 1991; 39 (1) 44-49
  • 50 Grunenwald DH, Mazel C, Girard P , et al. Radical en bloc resection for lung cancer invading the spine. J Thorac Cardiovasc Surg 2002; 123 (2) 271-279
  • 51 Mitchell JD, Mathisen DJ, Wright CD , et al. Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome. J Thorac Cardiovasc Surg 2001; 121 (3) 465-471
  • 52 Pitz CC, Brutel de la Rivière A, van Swieten HA, Westermann CJ, Lammers JW, van den Bosch JM. Results of surgical treatment of T4 non-small cell lung cancer. Eur J Cardiothorac Surg 2003; 24 (6) 1013-1018
  • 53 Osaki T, Sugio K, Hanagiri T , et al. Survival and prognostic factors of surgically resected T4 non-small cell lung cancer. Ann Thorac Surg 2003; 75 (6) 1745-1751 , discussion 1751
  • 54 Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987; 67 (5) 1037-1049
  • 55 Albain KS, Rusch VW, Crowley JJ , et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13 (8) 1880-1892
  • 56 Kim AW, Liptay MJ, Bonomi P , et al. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients. Ann Thorac Surg 2011; 92 (1) 233-241 ; discussion 241–243
  • 57 Albain KS, Swann RS, Rusch VW , et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009; 374 (9687) 379-386
  • 58 Harpole Jr DH, DeCamp Jr MM, Daley J , et al. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 1999; 117 (5) 969-979
  • 59 Licker MJ, Widikker I, Robert J , et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg 2006; 81 (5) 1830-1837
  • 60 Dominguez-Ventura A, Cassivi SD, Allen MS , et al. Lung cancer in octogenarians: factors affecting long-term survival following resection. Eur J Cardiothorac Surg 2007; 32 (2) 370-374
  • 61 Yim AP, Izzat MB, Liu HP, Ma CC. Thoracoscopic major lung resections: an Asian perspective. Semin Thorac Cardiovasc Surg 1998; 10 (4) 326-331
  • 62 Kaseda S, Aoki T, Hangai N. Video-assisted thoracic surgery (VATS) lobectomy: the Japanese experience. Semin Thorac Cardiovasc Surg 1998; 10 (4) 300-304
  • 63 Roviaro G, Varoli F, Vergani C, Maciocco M. Video-assisted thoracoscopic surgery (VATS) major pulmonary resections: the Italian experience. Semin Thorac Cardiovasc Surg 1998; 10 (4) 313-320